A
Armando Santoro
Researcher at Humanitas University
Publications - 961
Citations - 56759
Armando Santoro is an academic researcher from Humanitas University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 93, co-authored 847 publications receiving 48505 citations. Previous affiliations of Armando Santoro include Aix-Marseille University & University of Milan.
Papers
More filters
Journal ArticleDOI
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial.
Fabio Conforti,Paolo Andrea Zucali,Laura Pala,Chiara Catania,Vincenzo Bagnardi,Isabel Sanfeliu Sala,Paolo Della Vigna,Matteo Perrino,P. Zagami,Chiara Corti,Sara Stucchi,Massimo Barberis,Elena Guerini-Rocco,Benedetta Di Venosa,Fabio De Vincenzo,Nadia Cordua,Armando Santoro,Giuseppe Giaccone,Tommaso Martino De Pas +18 more
TL;DR: Avelumab combined with axitinib has promising anti-tumour activity and acceptable toxicity in patients with advanced type B3 thymoma and thymic carcinoma progressing after chemotherapy, and could emerge as a new standard treatment option in this setting as discussed by the authors .
Journal ArticleDOI
Prognostic factors and outcome of HER2+ breast cancer with CNS metastases
Giovanna Masci,Elisa Agostinetto,Laura Giordano,Giulia Bottai,Rosalba Torrisi,Agnese Losurdo,Rita De Sanctis,Piera Navarria,Marta Scorsetti,Monica Zuradelli,Fiorenza De Rose,Lorenzo Bello,Armando Santoro +12 more
TL;DR: Prognosis of BC patients with CNSm has improved using HER2-targeting therapies but remains poor, and outcome and prognostic factors in CNSm and non-CNSm patients are evaluated.
Journal ArticleDOI
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence.
Patricia Gomez-Rosas,Marina Pesenti,Cristina Verzeroli,Cinzia Giaccherini,Laura Russo,Roberta Sarmiento,Giovanna Masci,Luigi Celio,Mauro Minelli,Sara Gamba,Carmen J Tartari,Carlo Tondini,Francesco Giuliani,Fausto Petrelli,Andrea D'Alessio,Giampietro Gasparini,Roberto Labianca,Armando Santoro,Filippo de Braud,Marina Marchetti,Anna Falanga +20 more
TL;DR: In this article, the role of thrombin generation (TG) potential for early disease recurrence prediction by means of the fully automated ST Genesia system was validated by a prospective cohort of 522 patients from the HYPERCAN study with newly diagnosed resected high risk breast cancer.
Journal ArticleDOI
Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas
Luca Castagna,Alexia Bertuzzi,A Nozza,Licia Siracusano,Monica Balzarotti,Massimo Magagnoli,Barbara Sarina,I Timofeeva,M Sinnone,M.G. Grimoldi,M Farè,Armando Santoro +11 more
TL;DR: It is confirmed that a low intensity conditioning regimen for allogeneic stem cell transplantation is feasible and effective in heavily pretreated patients.
Journal ArticleDOI
Chemotherapy after PD‐1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics
Eleonora Calabretta,Anna Guidetti,Francesco Ricci,Martina Di Trani,C. Monfrini,Massimo Magagnoli,Stefania Bramanti,D. Maspero,Lucia Morello,Michele Merli,Alice Di Rocco,Alex Graudenzi,Enrico Derenzini,Marco Antoniotti,Davide Rossi,Paolo Corradini,Armando Santoro,Carmelo Carlo-Stella +17 more
TL;DR: Patients who fail CPIs can be effectively rescued by salvage chemotherapy and bridged to allo‐SCT/auto‐S NCT/auto-SCT in a manner similar to that of patients rescued by salvaging chemotherapy after CPI failure.